Sign inCreate account

Report workspace tools

NCT03381586COMPLETEDanonymous

QUILT-1.004: A Single Center, Open-label, Pharmacokinetic Study of Subcutaneous ALT-803

Sponsor

Source record

Altor BioScience

Phase

Source record

PHASE 1

Modality

AI-normalized

small molecule

Target

AI-normalized

ALT-803

Indication / condition

AI-normalized

Healthy

Intervention

Source record

ALT-803

Source & freshness

Source record

NCT ID

NCT03381586

Original source

ClinicalTrials.gov

Source last updated

Mar 24, 2025

Ingested at

May 23, 2026

Internal sync

Jun 05, 2026

Model version

trialsignal-ai-v1

Normalized confidence

88%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT03381586

Title

QUILT-1.004: A Single Center, Open-label, Pharmacokinetic Study of Subcutaneous ALT-803

Sponsor

Altor BioScience

Status

COMPLETED

Phase

PHASE 1

Condition raw

Healthy

Condition normalized

Healthy

Modality raw

Healthy

Modality normalized

small molecule

Target raw

ALT-803

Target normalized

ALT-803

Interventions

ALT-803

Public preview

Source record

This study, conducted by Altor BioScience, evaluated the pharmacokinetics of ALT-803, a drug administered subcutaneously to healthy volunteers. The trial aimed to understand the drug's absorption, distribution, metabolism, and excretion characteristics.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

QUILT-1.004: A Single Center, Open-label, Pharmacokinetic Study of Subcutaneous ALT-803

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT03381586

Status

COMPLETED

Phase

PHASE 1

Sponsor

Altor BioScience

Executive brief

Investment-Ready Snapshot

This study, conducted by Altor BioScience, evaluated the pharmacokinetics of ALT-803, a drug administered subcutaneously to healthy volunteers. The trial aimed to understand the drug's absorption, distribution, metabolism, and excretion characteristics.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedMar 24, 2025
Internal syncJun 05, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT03381586

Indication

Healthy

Modality

small molecule

Target

ALT-803

Intervention

ALT-803

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.